1. Synthesis and Biological Evaluation of 5'-O-Fatty Acyl Ester Derivatives of 3'-Fluoro-2',3'-dideoxythymidine as Potential anti-HIV Microbicides. Agarwal, H.K., B.S. Chhikara, G. Ye, S. Bhavaraju, A. Dixit, A. Kumar, G.F. Doncel, and K. Parang. Molecules, 2022. 27(10): 3352. PMID[35630829]. PMCID[PMC9143043].
[PubMed]. HIV_05_2022.
2. 4-(1-Benzyl-1H-benzo[d]imidazol-2-yl)-4-oxo-2-butenoic acid Derivatives: Design, Synthesis and Anti-HIV-1 Activity. Karimi, N., R.V. Roudsari, M.A. Movahed, Z. Hajimahdi, and A. Zarghi. Iranian Journal of Pharmaceutical Research, 2021. 20(1): p. 408-417. PMID[34400969]. PMCID[PMC8170749].
[PubMed]. HIV_05_2022
3. New Derivatives of 5-Substituted Uracils: Potential Agents with a Wide Spectrum of Biological Activity. Kezin, V.A., E.S. Matyugina, M.S. Novikov, A.O. Chizhov, R. Snoeck, G. Andrei, S.N. Kochetkov, and A.L. Khandazhinskaya. Molecules, 2022. 27(9): 2866. PMID[35566215]. PMCID[PMC9102953].
[PubMed]. HIV_05_2022
4. Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance. Lai, M.T., M. Feng, M. Xu, W. Ngo, T.L. Diamond, C. Hwang, J.A. Grobler, D.J. Hazuda, and E. Asante-Appiah. Antimicrobial Agents and Chemotherapy, 2022. 66(5): e0222321. PMID[35491829]. PMCID[PMC9112941].
[PubMed]. HIV_05_2022.
5. Leronlimab (Pro 140) in Vitro Activity Against 4-Class Drug Resistant HIV-1 from Heavily Treatment Experienced Subjects. Rusconi, S., F. Saladini, M.C. Bellocchi, L. Galli, R. Gagliardini, L. Gazzola, D. Francisci, F. Vichi, E. Foca, M. Zazzi, M.M. Santoro, A. Gabrieli, A. Castagna, and P.R.S. Grp. Pharmacological Research, 2022. 176: 106064. PMID[34999223].
[PubMed]. HIV_05_2022
6. Anti-HIV-1 Nanobody-IgG1 Constructs with Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions. Schriek, A.I., M.M. van Haaren, M. Poniman, G. Dekkers, A.E.H. Bentlage, M. Grobben, G. Vidarsson, R.W. Sanders, T. Verrips, T.B.H. Geijtenbeek, R. Heukers, N.A. Kootstra, S.W. de Taeye, and M.J. van Gils. Frontiers in Immunology, 2022. 13: 893648. PMID[35651621]. PMCID[PMC9150821].
[PubMed]. HIV_05_2022.
7. Design, Synthesis, and Bio-evaluation of Novel Triterpenoid Derivatives as anti-HIV-1 Compounds. Takeuchi, R., K. Ogihara, J. Fujimoto, K. Sato, N. Mase, K. Yoshimura, S. Harada, and T. Narumi. Bioorganic & Medicinal Chemistry Letters, 2022. 69: 128768. PMID[35513221].
[PubMed]. HIV_05_2022.
8. Design, Synthesis and Biological Studies of Some New Imidazole-1,2,3-triazole Hybrid Derivatives. Wu, J.G., G.Y. Huo, and H.R. Dong. Journal of Molecular Structure, 2022. 1256. ISI[000790010800003].
[WOS]. HIV_05_2022
Patent Citations
This month, no relevant HIV patents were identified.